Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Stevanović S[au]:

Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer. Stevanović S et al. Science. (2017)

The immunopeptidomic landscape of ovarian carcinomas. Schuster H et al. Proc Natl Acad Sci U S A. (2017)

Circulating Cell-free DNA for Metastatic Cervical Cancer Detection, Genotyping, and Monitoring. Kang Z et al. Clin Cancer Res. (2017)

Search results

Items: 1 to 50 of 400

1.

Measurements of Oxidative Potential of Particulate Matter at Belgrade Tunnel; Comparison of BPEAnit, DTT and DCFH Assays.

Jovanovic MV, Savic JZ, Salimi F, Stevanovic S, Brown RA, Jovasevic-Stojanovic M, Manojlovic D, Bartonova A, Bottle S, Ristovski ZD.

Int J Environ Res Public Health. 2019 Dec 5;16(24). pii: E4906. doi: 10.3390/ijerph16244906.

PMID:
31817307
2.

Comparison of fine particulate matter level, chemical content and oxidative potential derived from two dissimilar urban environments.

Jovanović MV, Savić J, Kovačević R, Tasić V, Todorović Ž, Stevanović S, Manojlović D, Jovašević-Stojanović M.

Sci Total Environ. 2019 Nov 22:135209. doi: 10.1016/j.scitotenv.2019.135209. [Epub ahead of print]

PMID:
31810686
3.

A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer.

Löffler MW, Nussbaum B, Jäger G, Jurmeister PS, Budczies J, Pereira PL, Clasen S, Kowalewski DJ, Mühlenbruch L, Königsrainer I, Beckert S, Ladurner R, Wagner S, Bullinger F, Gross TH, Schroeder C, Sipos B, Königsrainer A, Stevanović S, Denkert C, Rammensee HG, Gouttefangeas C, Haen SP.

Front Immunol. 2019 Nov 19;10:2526. doi: 10.3389/fimmu.2019.02526. eCollection 2019.

4.

Comparison of light absorption and oxidative potential of biodiesel/diesel and chemicals/diesel blends soot particles.

Kuang Y, Guo Y, Chai J, Shang J, Zhu J, Stevanovic S, Ristovski Z.

J Environ Sci (China). 2020 Jan;87:184-193. doi: 10.1016/j.jes.2019.06.014. Epub 2019 Jun 29.

PMID:
31791491
5.

A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer.

Rammensee HG, Wiesmüller KH, Chandran PA, Zelba H, Rusch E, Gouttefangeas C, Kowalewski DJ, Di Marco M, Haen SP, Walz JS, Gloria YC, Bödder J, Schertel JM, Tunger A, Müller L, Kießler M, Wehner R, Schmitz M, Jakobi M, Schneiderhan-Marra N, Klein R, Laske K, Artzner K, Backert L, Schuster H, Schwenck J, Weber ANR, Pichler BJ, Kneilling M, la Fougère C, Forchhammer S, Metzler G, Bauer J, Weide B, Schippert W, Stevanović S, Löffler MW.

J Immunother Cancer. 2019 Nov 15;7(1):307. doi: 10.1186/s40425-019-0796-5.

6.

Application of a Fluorescent Probe for the Online Measurement of PM-Bound Reactive Oxygen Species in Chamber and Ambient Studies.

Brown R, Stevanovic S, Brown Z, Cai M, Zhou S, Song W, Wang X, Miljevic B, Zhao J, Bottle S, Ristovski Z.

Sensors (Basel). 2019 Oct 21;19(20). pii: E4564. doi: 10.3390/s19204564.

7.

Effect of cold start on engine performance and emissions from diesel engines using IMO-Compliant distillate fuels.

Chu Van T, Zare A, Jafari M, Bodisco TA, Surawski N, Verma P, Suara K, Ristovski Z, Rainey T, Stevanovic S, Brown RJ.

Environ Pollut. 2019 Dec;255(Pt 2):113260. doi: 10.1016/j.envpol.2019.113260. Epub 2019 Sep 17.

PMID:
31622808
8.

MHCquant: Automated and Reproducible Data Analysis for Immunopeptidomics.

Bichmann L, Nelde A, Ghosh M, Heumos L, Mohr C, Peltzer A, Kuchenbecker L, Sachsenberg T, Walz JS, Stevanović S, Rammensee HG, Kohlbacher O.

J Proteome Res. 2019 Nov 1;18(11):3876-3884. doi: 10.1021/acs.jproteome.9b00313. Epub 2019 Oct 22.

PMID:
31589052
9.

HLA-B locus products resist degradation by the human cytomegalovirus immunoevasin US11.

Zimmermann C, Kowalewski D, Bauersfeld L, Hildenbrand A, Gerke C, Schwarzmüller M, Le-Trilling VTK, Stevanovic S, Hengel H, Momburg F, Halenius A.

PLoS Pathog. 2019 Sep 17;15(9):e1008040. doi: 10.1371/journal.ppat.1008040. eCollection 2019 Sep.

10.

Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1.

Marcinkowski B, Stevanović S, Helman SR, Norberg SM, Serna C, Jin B, Gkitsas N, Kadakia T, Warner A, Davis JL, Rooper L, Hinrichs CS.

J Immunother Cancer. 2019 Aug 28;7(1):229. doi: 10.1186/s40425-019-0678-x.

11.

T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial Cancers: A First-in-Human, Phase I/II Study.

Doran SL, Stevanović S, Adhikary S, Gartner JJ, Jia L, Kwong MLM, Faquin WC, Hewitt SM, Sherry RM, Yang JC, Rosenberg SA, Hinrichs CS.

J Clin Oncol. 2019 Oct 20;37(30):2759-2768. doi: 10.1200/JCO.18.02424. Epub 2019 Aug 13.

12.

Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy.

Blaeschke F, Paul MC, Schuhmann MU, Rabsteyn A, Schroeder C, Casadei N, Matthes J, Mohr C, Lotfi R, Wagner B, Kaeuferle T, Feucht J, Willier S, Handgretinger R, StevanoviĆ S, Lang P, Feuchtinger T.

Cytotherapy. 2019 Sep;21(9):973-986. doi: 10.1016/j.jcyt.2019.06.009. Epub 2019 Jul 25.

PMID:
31351799
13.

The cytotoxic, inflammatory and oxidative potential of coconut oil-substituted diesel emissions on bronchial epithelial cells at an air-liquid interface.

Vaughan A, Stevanovic S, Banks APW, Zare A, Rahman MM, Bowman RV, Fong KM, Ristovski ZD, Yang IA.

Environ Sci Pollut Res Int. 2019 Sep;26(27):27783-27791. doi: 10.1007/s11356-019-05959-5. Epub 2019 Jul 24.

PMID:
31342346
14.

Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer.

Audehm S, Glaser M, Pecoraro M, Bräunlein E, Mall S, Klar R, Effenberger M, Albers J, Bianchi HO, Peper J, Yusufi N, Busch DH, Stevanović S, Mann M, Antes I, Krackhardt AM.

Front Immunol. 2019 Jun 28;10:1485. doi: 10.3389/fimmu.2019.01485. eCollection 2019.

15.

Chain Formation of Laryngeal Granulomas on the Epiglottis After Iatrogenic Trauma.

Oreški I, Gregurić T, Aras I, Mašić S, Stevanović S.

Ear Nose Throat J. 2019 Jul 2:145561319861385. doi: 10.1177/0145561319861385. [Epub ahead of print] No abstract available.

PMID:
31266400
16.

Identification of MHC Ligands and Establishing MHC Class I Peptide Motifs.

Ghosh M, Di Marco M, Stevanović S.

Methods Mol Biol. 2019;1988:137-147. doi: 10.1007/978-1-4939-9450-2_11.

PMID:
31147938
17.

Purification and Identification of Naturally Presented MHC Class I and II Ligands.

Nelde A, Kowalewski DJ, Stevanović S.

Methods Mol Biol. 2019;1988:123-136. doi: 10.1007/978-1-4939-9450-2_10.

PMID:
31147937
18.

Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy.

Murphy JP, Kim Y, Clements DR, Konda P, Schuster H, Kowalewski DJ, Paulo JA, Cohen AM, Stevanovic S, Gygi SP, Gujar S.

J Proteome Res. 2019 Jun 7;18(6):2666-2675. doi: 10.1021/acs.jproteome.9b00173. Epub 2019 May 29.

PMID:
31095916
19.

Quantification of Particle-Bound Organic Radicals in Secondary Organic Aerosol.

Campbell SJ, Stevanovic S, Miljevic B, Bottle SE, Ristovski Z, Kalberer M.

Environ Sci Technol. 2019 Jun 18;53(12):6729-6737. doi: 10.1021/acs.est.9b00825. Epub 2019 May 24.

PMID:
31075990
20.

Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma.

Löffler MW, Mohr C, Bichmann L, Freudenmann LK, Walzer M, Schroeder CM, Trautwein N, Hilke FJ, Zinser RS, Mühlenbruch L, Kowalewski DJ, Schuster H, Sturm M, Matthes J, Riess O, Czemmel S, Nahnsen S, Königsrainer I, Thiel K, Nadalin S, Beckert S, Bösmüller H, Fend F, Velic A, Maček B, Haen SP, Buonaguro L, Kohlbacher O, Stevanović S, Königsrainer A; HEPAVAC Consortium, Rammensee HG.

Genome Med. 2019 Apr 30;11(1):28. doi: 10.1186/s13073-019-0636-8.

21.

Targeting self and neo-epitopes with a modular self-adjuvanting cancer vaccine.

Belnoue E, Mayol JF, Carboni S, Di Berardino Besson W, Dupuychaffray E, Nelde A, Stevanovic S, Santiago-Raber ML, Walker PR, Derouazi M.

JCI Insight. 2019 Apr 23;5. pii: 127305. doi: 10.1172/jci.insight.127305.

22.

Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-Targets.

Stevanovic S, Sencanski M, Danel M, Menendez C, Belguedj R, Bouraiou A, Nikolic K, Cojean S, Loiseau PM, Glisic S, Baltas M, García-Sosa AT.

Molecules. 2019 Apr 2;24(7). pii: E1282. doi: 10.3390/molecules24071282.

23.

A Case Report of Solitary Extramedullary Plasmacytoma of the Cricoid Cartilage Diagnosed After Total Thyroidectomy.

Čunović N, Košec A, Stevanović S, Bedeković V.

Ear Nose Throat J. 2019 Apr 9:145561319839634. doi: 10.1177/0145561319839634. [Epub ahead of print] No abstract available.

PMID:
30966804
24.

Regulatory T Cells in an Endogenous Mouse Lymphoma Recognize Specific Antigen Peptides and Contribute to Immune Escape.

Ahmetlić F, Riedel T, Hömberg N, Bauer V, Trautwein N, Geishauser A, Sparwasser T, Stevanović S, Röcken M, Mocikat R.

Cancer Immunol Res. 2019 Apr;7(4):600-608. doi: 10.1158/2326-6066.CIR-18-0419. Epub 2019 Mar 20.

PMID:
30894379
25.

On optimal and near-optimal shapes of external shading of windows in apartment buildings.

Stevanović S, Stevanović D, Dehmer M.

PLoS One. 2019 Feb 28;14(2):e0212710. doi: 10.1371/journal.pone.0212710. eCollection 2019.

26.

Multiplexed Relative Quantitation with Isobaric Tagging Mass Spectrometry Reveals Class I Major Histocompatibility Complex Ligand Dynamics in Response to Doxorubicin.

Murphy JP, Yu Q, Konda P, Paulo JA, Jedrychowski MP, Kowalewski DJ, Schuster H, Kim Y, Clements D, Jain A, Stevanovic S, Gygi SP, Mancias JD, Gujar S.

Anal Chem. 2019 Apr 16;91(8):5106-5115. doi: 10.1021/acs.analchem.8b05616. Epub 2019 Feb 22.

PMID:
30779550
27.

Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in Glioblastoma.

Rajaraman S, Canjuga D, Ghosh M, Codrea MC, Sieger R, Wedekink F, Tatagiba M, Koch M, Lauer UM, Nahnsen S, Rammensee HG, Mühlebach MD, Stevanovic S, Tabatabai G.

Mol Ther Oncolytics. 2018 Dec 31;12:147-161. doi: 10.1016/j.omto.2018.12.010. eCollection 2019 Mar 29.

28.

Primary human bronchial epithelial cell responses to diesel and biodiesel emissions at an air-liquid interface.

Vaughan A, Stevanovic S, Jafari M, Bowman RV, Fong KM, Ristovski ZD, Yang IA.

Toxicol In Vitro. 2019 Jun;57:67-75. doi: 10.1016/j.tiv.2019.02.005. Epub 2019 Feb 7.

PMID:
30738890
29.

Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma.

Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanović S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Straten PT, Martinez-Ricarte F, Ponsati B, Okada H, Lassen U, Admon A, Ottensmeier CH, Ulges A, Kreiter S, von Deimling A, Skardelly M, Migliorini D, Kroep JR, Idorn M, Rodon J, Piro J, Poulsen HS, Shraibman B, McCann K, Mendrzyk R, Lower M, Stieglbauer M, Britten CM, Capper D, Welters MJP, Sahuquillo J, Kiesel K, Derhovanessian E, Rusch E, Bunse L, Song C, Heesch S, Wagner C, Kemmer-Bruck A, Ludwig J, Castle JC, Schoor O, Tadmor AD, Green E, Fritsche J, Meyer M, Pawlowski N, Dorner S, Hoffgaard F, Rossler B, Maurer D, Weinschenk T, Reinhardt C, Huber C, Rammensee HG, Singh-Jasuja H, Sahin U, Dietrich PY, Wick W.

Nature. 2019 Feb;566(7745):E13. doi: 10.1038/s41586-019-0959-z.

PMID:
30733620
30.

Human Papillomavirus T-Cell Cross-reactivity in Cervical Cancer: Implications for Immunotherapy Clinical Trial Design.

Helman SR, Stevanovic S, Campbell TE, Kwong MLM, Doran SL, Faquin WC, Hinrichs CS.

JAMA Netw Open. 2018 Jul 6;1(3):e180706. doi: 10.1001/jamanetworkopen.2018.0706.

31.

Tumor-infiltrating human CD4+ regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity.

Ahmadzadeh M, Pasetto A, Jia L, Deniger DC, Stevanović S, Robbins PF, Rosenberg SA.

Sci Immunol. 2019 Jan 11;4(31). pii: eaao4310. doi: 10.1126/sciimmunol.aao4310.

32.

The effect of diesel emission exposure on primary human bronchial epithelial cells from a COPD cohort: N-acetylcysteine as a potential protective intervention.

Vaughan A, Stevanovic S, Jafari M, Rahman M, Bowman RV, Fong KM, Ristovski Z, Yang IA.

Environ Res. 2019 Mar;170:194-202. doi: 10.1016/j.envres.2018.12.035. Epub 2018 Dec 18.

PMID:
30590262
33.

Actively personalized vaccination trial for newly diagnosed glioblastoma.

Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanović S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Thor Straten P, Martínez-Ricarte F, Ponsati B, Okada H, Lassen U, Admon A, Ottensmeier CH, Ulges A, Kreiter S, von Deimling A, Skardelly M, Migliorini D, Kroep JR, Idorn M, Rodon J, Piró J, Poulsen HS, Shraibman B, McCann K, Mendrzyk R, Löwer M, Stieglbauer M, Britten CM, Capper D, Welters MJP, Sahuquillo J, Kiesel K, Derhovanessian E, Rusch E, Bunse L, Song C, Heesch S, Wagner C, Kemmer-Brück A, Ludwig J, Castle JC, Schoor O, Tadmor AD, Green E, Fritsche J, Meyer M, Pawlowski N, Dorner S, Hoffgaard F, Rössler B, Maurer D, Weinschenk T, Reinhardt C, Huber C, Rammensee HG, Singh-Jasuja H, Sahin U, Dietrich PY, Wick W.

Nature. 2019 Jan;565(7738):240-245. doi: 10.1038/s41586-018-0810-y. Epub 2018 Dec 19. Erratum in: Nature. 2019 Feb;566(7745):E13.

PMID:
30568303
34.

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy.

Bilich T, Nelde A, Bichmann L, Roerden M, Salih HR, Kowalewski DJ, Schuster H, Tsou CC, Marcu A, Neidert MC, Lübke M, Rieth J, Schemionek M, Brümmendorf TH, Vucinic V, Niederwieser D, Bauer J, Märklin M, Peper JK, Klein R, Kohlbacher O, Kanz L, Rammensee HG, Stevanović S, Walz JS.

Blood. 2019 Feb 7;133(6):550-565. doi: 10.1182/blood-2018-07-866830. Epub 2018 Dec 10.

PMID:
30530751
35.

A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial Cancers.

Stevanović S, Helman SR, Wunderlich JR, Langhan MM, Doran SL, Kwong MLM, Somerville RPT, Klebanoff CA, Kammula US, Sherry RM, Yang JC, Rosenberg SA, Hinrichs CS.

Clin Cancer Res. 2019 Mar 1;25(5):1486-1493. doi: 10.1158/1078-0432.CCR-18-2722. Epub 2018 Dec 5.

36.

TAPBPR mediates peptide dissociation from MHC class I using a leucine lever.

Ilca FT, Neerincx A, Hermann C, Marcu A, Stevanović S, Deane JE, Boyle LH.

Elife. 2018 Nov 28;7. pii: e40126. doi: 10.7554/eLife.40126.

37.

Characterization particulate matter from several Chinese cooking dishes and implications in health effects.

Wang L, Zheng X, Stevanovic S, Wu X, Xiang Z, Yu M, Liu J.

J Environ Sci (China). 2018 Oct;72:98-106. doi: 10.1016/j.jes.2017.12.015. Epub 2018 Jan 4.

PMID:
30244755
38.

Optimisation of curvilinear external shading of windows in cellular offices.

Stevanović S, Stevanović D.

PLoS One. 2018 Sep 7;13(9):e0203575. doi: 10.1371/journal.pone.0203575. eCollection 2018.

39.

Emissions of particulate matter, carbon monoxide and nitrogen oxides from the residential burning of waste paper briquettes and other fuels.

Xiu M, Stevanovic S, Rahman MM, Pourkhesalian AM, Morawska L, Thai PK.

Environ Res. 2018 Nov;167:536-543. doi: 10.1016/j.envres.2018.08.008. Epub 2018 Aug 6.

PMID:
30142630
40.

Identification of non-mutated neoantigens presented by TAP-deficient tumors.

Marijt KA, Blijleven L, Verdegaal EME, Kester MG, Kowalewski DJ, Rammensee HG, Stevanović S, Heemskerk MHM, van der Burg SH, van Hall T.

J Exp Med. 2018 Sep 3;215(9):2325-2337. doi: 10.1084/jem.20180577. Epub 2018 Aug 16.

41.

Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

Gravett AM, Trautwein N, Stevanović S, Dalgleish AG, Copier J.

Oncoimmunology. 2018 Mar 6;7(6):e1438107. doi: 10.1080/2162402X.2018.1438107. eCollection 2018.

42.

Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation.

Löffler MW, Kowalewski DJ, Backert L, Bernhardt J, Adam P, Schuster H, Dengler F, Backes D, Kopp HG, Beckert S, Wagner S, Königsrainer I, Kohlbacher O, Kanz L, Königsrainer A, Rammensee HG, Stevanović S, Haen SP.

Cancer Res. 2018 Aug 15;78(16):4627-4641. doi: 10.1158/0008-5472.CAN-17-1745. Epub 2018 May 22.

43.

Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.

Jin BY, Campbell TE, Draper LM, Stevanović S, Weissbrich B, Yu Z, Restifo NP, Rosenberg SA, Trimble CL, Hinrichs CS.

JCI Insight. 2018 Apr 19;3(8). pii: 99488. doi: 10.1172/jci.insight.99488. eCollection 2018 Apr 19.

44.

Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry.

Freudenmann LK, Marcu A, Stevanović S.

Immunology. 2018 Jul;154(3):331-345. doi: 10.1111/imm.12936. Epub 2018 May 8. Review.

45.

HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy.

Nelde A, Kowalewski DJ, Backert L, Schuster H, Werner JO, Klein R, Kohlbacher O, Kanz L, Salih HR, Rammensee HG, Stevanović S, Walz JS.

Oncoimmunology. 2018 Feb 14;7(4):e1316438. doi: 10.1080/2162402X.2017.1316438. eCollection 2018.

46.

In Silico Discovery of a Substituted 6-Methoxy-quinalidine with Leishmanicidal Activity in Leishmania infantum.

Stevanović S, Perdih A, Senćanski M, Glišić S, Duarte M, Tomás AM, Sena FV, Sousa FM, Pereira MM, Solmajer T.

Molecules. 2018 Mar 27;23(4). pii: E772. doi: 10.3390/molecules23040772.

47.

Peptide-Based Sandwich Immunoassay for the Quantification of the Membrane Transporter Multidrug Resistance Protein 1.

Poetz O, Dieze T, Hammer H, Weiß F, Sommersdorf C, Templin MF, Esdar C, Zimmermann A, Stevanovic S, Bedke J, Stenzl A, Joos TO.

Anal Chem. 2018 May 1;90(9):5788-5794. doi: 10.1021/acs.analchem.8b00152. Epub 2018 Apr 12.

PMID:
29570278
48.

The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy.

Neidert MC, Kowalewski DJ, Silginer M, Kapolou K, Backert L, Freudenmann LK, Peper JK, Marcu A, Wang SS, Walz JS, Wolpert F, Rammensee HG, Henschler R, Lamszus K, Westphal M, Roth P, Regli L, Stevanović S, Weller M, Eisele G.

Acta Neuropathol. 2018 Jun;135(6):923-938. doi: 10.1007/s00401-018-1836-9. Epub 2018 Mar 20.

PMID:
29557506
49.

Improved Ribo-seq enables identification of cryptic translation events.

Erhard F, Halenius A, Zimmermann C, L'Hernault A, Kowalewski DJ, Weekes MP, Stevanovic S, Zimmer R, Dölken L.

Nat Methods. 2018 May;15(5):363-366. doi: 10.1038/nmeth.4631. Epub 2018 Mar 12.

50.

A GPS Phase-Locked Loop Performance Metric Based on the Phase Discriminator Output.

Stevanovic S, Pervan B.

Sensors (Basel). 2018 Jan 19;18(1). pii: E296. doi: 10.3390/s18010296.

Supplemental Content

Loading ...
Support Center